Progress in Cell Surface Biomarker Detection: Emphasizing Estrogen Receptor Profiling for Cancer Diagnostics
Received Date: Nov 01, 2023 / Published Date: Nov 30, 2023
Abstract
The detection and analysis of cell surface biomarkers, particularly the estrogen receptor (ER), play a pivotal role in the diagnosis and treatment of various cancers, including breast cancer. This paper reviews recent advancements in methodologies and technologies for the detection of cell surface biomarkers, with a specific emphasis on estrogen receptor profiling. We begin by discussing the significance of ER as a biomarker in oncology, outlining its role in disease progression and therapeutic targeting. Subsequently, we delve into traditional methods of ER detection, such as immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH), and highlight their limitations, including issues with sensitivity and quantification [1].
Citation: Hao J (2023) Progress in Cell Surface Biomarker Detection: Emphasizing Estrogen Receptor Profiling for Cancer Diagnostics. J Cancer Diagn 7: 208.
Copyright: © 2023 Hao J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Usage
- Total views: 337
- [From(publication date): 0-2024 - Nov 22, 2024]
- Breakdown by view type
- HTML page views: 272
- PDF downloads: 65
